Common Consumer Vocabulary
- grounded
- settled
- body-aware
Descriptive language, not a clinical outcome scale.
A peppery sesquiterpene that activated CB2 in receptor assays and mice.
Identity and Cannabis Context
Beta-caryophyllene is often measured in cannabis and differs from its oxidation product, caryophyllene oxide.
People commonly describe isolated beta-caryophyllene with black pepper, spice, wood notes. A finished flower or extract contains a more complex volatile mixture.
Experience Lens
People often use words like grounded, settled, body-aware when talking about products that feature Beta-Caryophyllene. Those words are useful for describing expectations and personal notes; they are not evidence that this terpene alone causes a predictable feeling.
Descriptive language, not a clinical outcome scale.
A laboratory and mouse study described selective CB2 agonism, making the compound mechanistically interesting rather than clinically proven.
Compare the exact batch, cannabinoid dose, route, setting, and your own response. Change one variable at a time when practical.
Laboratory research only
A laboratory and mouse study described selective CB2 agonism, making the compound mechanistically interesting rather than clinically proven.
Beta-caryophyllene acted as a selective CB2 agonist in receptor assays and reduced inflammation in mouse models.
Limit: Receptor and mouse results are not evidence of clinical benefit.
Sources: Beta-caryophyllene is a dietary cannabinoid (opens in new tab)
No controlled human cannabis study establishes anti-inflammatory, pain, anxiety, or neuroprotective benefit from product-level exposure.
A certificate of analysis identifies composition, not a safe or effective dose. Inhalation can irritate airways, and heating terpenes can create degradation products.
This page is educational and does not provide medical advice. Route, dose, oxidation, heat, other ingredients, and individual health conditions all change risk.
This bounded preview shows records whose available profile contains Beta-Caryophyllene. It is not a total, a dominant-terpene ranking, or a guarantee about a current retail batch.
Proceedings of the National Academy of Sciences, 2008 • laboratory
Frontiers in Pharmacology, 2020 • laboratory
New York State Office of Cannabis Management, 2026 • chemistry
Older deep dive: Beta-Caryophyllene article. This profile is the current evidence summary.
Beta-Caryophyllene (β-Caryophyllene) is a peppery sesquiterpene that activated CB2 in receptor assays and mice. Beta-caryophyllene is often measured in cannabis and differs from its oxidation product, caryophyllene oxide.
Common descriptors include black pepper, spice, wood. Aroma is subjective, and other volatile compounds in the tested product also matter.
A laboratory and mouse study described selective CB2 agonism, making the compound mechanistically interesting rather than clinically proven. No controlled human cannabis study establishes anti-inflammatory, pain, anxiety, or neuroprotective benefit from product-level exposure.
No. A lab result identifies chemistry in one sample. It does not guarantee a feeling, benefit, dose, or response for an individual consumer.
Compare all 26 profiles, their aliases, and their evidence limits.
Browse all terpene profiles